期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
卷 40, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13046-021-02133-z
关键词
Biomarker; Immune checkpoint inhibitor; Immunotherapy; T cells; Tumor fibrosis; Fibroblasts; Collagen; Extracellular matrix
类别
资金
- Danish Research Foundation (Den Danske Forskningsfond)
Despite the overall clinical success of ICIs for treating patients with solid tumors, a large number of patients do not benefit from this approach. The most prevalent biomarkers do not reliably predict response to ICIs across different solid tumor types, indicating a need for a broader view in predictive biomarkers. Fibrotic activity characterized by ECM and collagen production by CAFs may be a central common denominator of resistance to ICIs.
Despite the overall clinical success of immune checkpoint inhibitors (ICIs) for treating patients with solid tumors, a large number of patients do not benefit from this approach. Consequently, there is a need for predictive biomarkers. The most prevalent biomarkers such as PD-L1 expression and tumor mutational burden (TMB) do not reliably predict response to ICIs across different solid tumor types suggesting that a broader view of regulating factors in the tumor microenvironment is needed. Emerging evidence indicates that one central common denominator of resistance to ICIs may be fibrotic activity characterized by extracellular matrix (ECM) and collagen production by cancer-associated fibroblasts (CAFs). A fibroblast-and collagen-rich stroma attenuates immunotherapy response by contributing to inhibition and exclusion of T cells. Here we review opportunities and limitations in the utilization of the most prevalent biomarkers for ICIs and elaborate on the unique opportunities with biomarkers originating from the activated fibroblasts producing an impermeable ECM. We propose that ECM and collagen biomarkers measured non-invasively may be a novel and practical approach to optimize treatment strategies and improve patient selection for ICI therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据